Search

Your search keyword '"Fisher B."' showing total 4,073 results

Search Constraints

Start Over You searched for: Author "Fisher B." Remove constraint Author: "Fisher B."
4,073 results on '"Fisher B."'

Search Results

Catalog

Books, media, physical & digital resources

4. Inter-grain tunnelling in the half-metallic double-perovskites Sr2BB'O6 (BB'= FeMo, FeRe, CrMo, CrW, CrRe)

5. Effect of heat treatment on the current induced dynamic mixed metal-insulator phase in needle-like VO2 single crystals

6. Electric-field effects in resistive oxides: facts and artifacts

7. EgoCoder: Intelligent Program Synthesis with Hierarchical Sequential Neural Network Model

8. GADAM: Genetic-Evolutionary ADAM for Deep Neural Network Optimization

9. Reconciled Polynomial Machine: A Unified Representation of Shallow and Deep Learning Models

10. On Deep Ensemble Learning from a Function Approximation Perspective

11. GEN Model: An Alternative Approach to Deep Neural Network Models

12. SEGEN: Sample-Ensemble Genetic Evolutional Network Model

13. CHAPTER 5 HUMAN ECOLOGY

14. Invertebrates part 1

15. Invertebrates part 3

16. Systane iLux Thermal Pulsation System in the Treatment of Meibomian Gland Dysfunction: A Post-Hoc Analysis of a 12-Month, Randomized, Multicenter Study

17. Transfer of Graphene with Protective Oxide Layers

21. Range Safety Considerations for Processing and Launching Reactor-Based Space Nuclear Systems.

23. OP0040 DOSE DEPENDENT MODULATION OF PROTEOMIC SIGNATURES BY IANALUMAB IN PATIENTS WITH SJÖGREN’S DISEASE

25. OP0008 SAFETY AND EFFICACY OF ISCALIMAB IN PATIENTS WITH SJÖGREN’S DISEASE: 48-WEEK RESULTS FROM A RANDOMISED, PLACEBO-CONTROLLED, PHASE 2B DOSE-RANGING TRIAL

26. AB1034 CHARACTERIZATION OF RO7507062, A CD19-TARGETING T-CELL BISPECIFIC ANTIBODY (CD19TCB), AND DESIGN OF A PHASE 1 TRIAL IN SYSTEMIC LUPUS ERYTHEMATOSUS

27. Efficacité et sécurité de l’iscalimab (un AcM anti-CD40) chez les patients atteints de maladie de Sjögren : résultats à 48 semaines d’un essai de phase 2b, randomisé et contrôlé par placebo (TWINSS)

28. Modulation dose-dépendante des signatures protéomiques par le ianalumab chez les patients atteints de la maladie de Sjögren

29. POS0375 ASSESSMENT OF S95011 (OSE-127, LUSVERTIKIMAB), AN ANTI-INTERLEUKIN 7 RECEPTOR MONOCLONAL ANTIBODY, IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME: AN INTERNATIONAL MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2A STUDY

30. The Global Ant Genomics Alliance (GAGA)

31. Systematics in the metal-insulator transition temperatures in vanadium oxides

32. Two insulator-insulator transitions in Al-doped VO2 single crystals.

34. Metal-insulator transition upon heating and negative-differential-resistive-switching induced by self-heating in BaCo0.9Ni0.1S1.8

36. Fast Neutron Detection with 6Li-loaded Liquid Scintillator

37. Absence of charge-density-wave sliding in epitaxial charge-ordered Pr0.48Ca0.52MnO3 films

40. Proton-$^{3}$He elastic scattering at low energies

41. Pulsed versus DC I-V characteristics of resistive manganites

42. Precision Measurements of d(d,p)t and d(d,n)^3He Total Cross Sections at Big-Bang Nucleosynthesis Energies

43. Muon Spin Relaxation Measurements in Na_xCoO_2*yH_2O

44. Impulse distributions in dense granular flows: signatures of large-scale spatial structures

45. Low-energy p-d Scattering: High Precision Data, Comparisons with Theory, and Phase-Shift Analyses

46. Evidence for Three Nucleon Force Effects in p-d Elastic Scattering